Affiliations 

  • 1 University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia
  • 2 Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. reena@um.edu.my
  • 3 Centre of Excellence for Research in AIDS (CERIA), University of Malaya, 50603, Kuala Lumpur, Malaysia
  • 4 Departments of Microbiology and Medicine, New York University School of Medicine, New York, NY, 10016, USA
  • 5 University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia. hany@ummc.edu.my
  • 6 Departments of Microbiology and Medicine, New York University School of Medicine, New York, NY, 10016, USA. png.loke@nyumc.org
Microbiome, 2017 03 20;5(1):35.
PMID: 28320465 DOI: 10.1186/s40168-017-0250-1

Abstract

BACKGROUND: Adult survivors of childhood cancers such as acute lymphoblastic leukemia (ALL) have health problems that persist or develop years after cessation of therapy. These late effects include chronic inflammation-related comorbidities such as obesity and type 2 diabetes, but the underlying cause is poorly understood.

RESULTS: We compared the anal microbiota composition of adult survivors of childhood ALL (N = 73) with healthy control subjects (N = 61). We identified an altered community with reduced microbial diversity in cancer survivors, who also exhibit signs of immune dysregulation including increased T cell activation and chronic inflammation. The bacterial community among cancer survivors was enriched for Actinobacteria (e.g. genus Corynebacterium) and depleted of Faecalibacterium, correlating with plasma concentrations of IL-6 and CRP and HLA-DR+CD4+ and HLA-DR+CD8+ T cells, which are established markers of inflammation and immune activation.

CONCLUSIONS: We demonstrated a relationship between microbial dysbiosis and immune dysregulation in adult ALL survivors. These observations suggest that interventions that could restore microbial diversity may ameliorate chronic inflammation and, consequently, development of late effects of childhood cancer survivors.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.